drugset / Trial / NCT02656810

A Comparison Study of PF708 and Forteo in Healthy Subjects

NCT02656810

Phase 1 Completed 70 enrolled Pfenex, Inc
RandomizedCrossoverQuadruple-blindTreatment

Summary

The purpose of this study is to compare the pharmacokinetics (blood levels) of two teriparatide products, PF708 and Forteo, in healthy subjects.

Timeline

Start
2015-12
Primary completion
2016-07
Completion
2016-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Teriparatide Protein / enzyme biologic Subcutaneous

Indications